Tim Wilsdon is speaking during the conference in a session titled “Improving Patient Access to Innovative Cancer Therapies: The Role of Managed Entry Agreements.”
For more information on this event, click here.
Potential impact of a second Trump term on US healthcare policy
Similarly, with a Republican majority in the US House and Senate, it is unknown what the legislative agenda for 2025 will look like and how the nation’s public...